Hudson CEO appointed to NHMRC Council
Hudson Institute of Medical Research Director and CEO Professor Elizabeth Hartland has been appointed to the Council of the National Health and Medical Research Council (NHMRC).
Professor Hartland will join 12 other leading medical researchers, academics, clinicians and administrators on the Council. Her 3-year term begins immediately, and she joins a distinguished group entrusted with the responsibility of guiding Australians’ current and future health.
“This is clearly a crucial time for the medical sector,” Professor Hartland said.
“It has never been more important to ensure that Australians have access to authoritative, evidence-based health advice.”
Professor Hartland is an international leader in the field of microbiology and immunology who brings a wealth of experience to the role beyond her specialty area of microbial drug resistance.
She has held a Royal Society/NHMRC Howard Florey Fellowship in the Department of Biochemistry, Imperial College London and Lecturer/Senior Lecturer positions at Monash University.
As well as her role at Hudson Institute, which she has held since 2017, Professor Hartland is Head of the Department of Molecular and Translational Science at Monash University.
“As the nation’s leading expert body in health and medical research, the NHMRC has a proud history of serving and protecting Australians; I look forward to the opportunity to play a part in that vital work,” she said.
Whiteley opens $25m Human Therapeutics Plant in the Hunter
Human Therapeutics Plant, a new $25 million facility for the manufacture of alcohol-based hand...
NSW announces legislative approach to Northern Beaches Hospital
Amendments have been announced that will allow NSW, if required, to terminate the Northern...
First public warning issued under new laws
For the first time since its power to issue public statements came into force two years...
